- The US FDA approved AbbVie's drug for Parkinson's disease, per Reuters.
- The approval adds a Parkinson's disease therapy to AbbVie's commercial portfolio.
Quotes
“US FDA approves AbbVie's drug for Parkinson's disease”
“US FDA approves AbbVie's drug for Parkinson's disease”— Reuters